Journal article · 2024 · Open access
Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making
Drug Safety, 47(5), 495–511 · Published 6 March 2024 · DOI 10.1007/s40264-024-01409-5
In brief
“Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making” is a 2024 journal article by Didrik Wessel and Nicolai Pogrebnyakov, published in Drug Safety. OpenAlex counts 24 citations as of 22 November 2026, which puts it in the top 3% of works published in 2024 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Drug Safety.
- Citations
- 24
- Most cited in
- 2026 (11)
- Field-weighted impact
- 5.12
- References
- 71
- Authors
- 2
Abstract
INTRODUCTION: While pharmaceutical companies aim to leverage real-world data (RWD) to bridge the gap between clinical drug development and real-world patient outcomes, extant research has mainly focused on the use of social media in a post-approval safety-surveillance setting. Recent regulatory and technological developments indicate that social media may serve as a rich source to expand the evidence base to pre-approval and drug development activities. However, use cases related to drug development have been largely omitted, thereby missing some of the benefits of RWD. In addition, an applied end-to-end understanding of RWD rooted in both industry and regulations is lacking. OBJECTIVE: We aimed to investigate how social media can be used as a source of RWD to support regulatory decision making and drug development in the pharmaceutical industry. We aimed to specifically explore the data pipeline and examine how social-media derived RWD can align with regulatory guidance from the US Food and Drug Administration and industry needs. METHODS: A machine learning pipeline was developed to extract patient insights related to anticoagulants from X (Twitter) data. These findings were then analysed from an industry perspective, and complemented by interviews with professionals from a pharmaceutical company. RESULTS: The analysis reveals several use cases where RWD derived from social media can be beneficial, particularly in generating hypotheses around patient and therapeutic area needs. We also note certain limitations of social media data, particularly around inferring causality. CONCLUSIONS: Social media display considerable potential as a source of RWD for guiding efforts in pharmaceutical drug development and pre-approval settings. Although further regulatory guidance on the use of social media for RWD is needed to encourage its use, regulatory and technological developments are suggested to warrant at least exploratory uses for drug development.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wessel, D., & Pogrebnyakov, N. (2024). Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making. Drug Safety, 47(5), 495–511. https://doi.org/10.1007/s40264-024-01409-5
MLA 9
Wessel, Didrik, and Nicolai Pogrebnyakov. “Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making.” Drug Safety, vol. 47, no. 5, 2024, pp. 495–511. https://doi.org/10.1007/s40264-024-01409-5.
Chicago
Wessel, Didrik and Nicolai Pogrebnyakov. 2024. “Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making.” Drug Safety 47 (5): 495–511. https://doi.org/10.1007/s40264-024-01409-5.
Harvard
Wessel, D. and Pogrebnyakov, N. (2024) ‘Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making’, Drug Safety, 47(5), pp. 495–511. doi:10.1007/s40264-024-01409-5.
IEEE
D. Wessel and N. Pogrebnyakov, “Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making,” Drug Safety, vol. 47, no. 5, pp. 495–511, 2024, doi: 10.1007/s40264-024-01409-5.
BibTeX
@article{wessel2024using,
title = {{Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making}},
author = {Wessel, Didrik and Pogrebnyakov, Nicolai},
journal = {Drug Safety},
year = {2024},
volume = {47},
number = {5},
pages = {495--511},
doi = {10.1007/s40264-024-01409-5},
url = {https://doi.org/10.1007/s40264-024-01409-5}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 6 | |
| 2025 | 7 | |
| 2026 | 11 |
Its field-weighted citation impact is 5.12: it has been cited 5.12 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- social media
- real-world data
- drug development
- regulatory decision-making
- anticoagulants
- FDA regulatory guidance
- hypothesis generation
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Wessel, D., & Pogrebnyakov, N. (2024). Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making. Drug Safety, 47(5), 495–511. https://doi.org/10.1007/s40264-024-01409-5
How many times has this paper been cited?
24 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Drug Safety: sign in and open the PDF from this page.
Who wrote this paper?
Didrik Wessel, Nicolai Pogrebnyakov.
What is the DOI of this paper?
10.1007/s40264-024-01409-5, permanently at https://doi.org/10.1007/s40264-024-01409-5. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.